Elevara Medicines
PrivateLast Round
Series A
Oct 22, 2025
Total Funding Raised
$70M
Company Overview
Elevara Medicines is a clinical-stage biopharmaceutical company developing new therapeutics to treat rheumatoid arthritis and other chronic inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
rheumatoid arthritis therapyCDK4/6 inhibitororal RA treatmentnon-immunosuppressive therapysmall molecule drugsRAFLS targetingfirst-in-class drugadd-on therapyinflammatory disease therapyclinical-stage biotechdrug developmentfibroblast-like synoviocytesFLSdrug in-licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elevara Medicines Comps
Public and private peers based on sector, stage, and business model.
Elevara Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 22, 2025 |
Elevara Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Monograph Capital | Series A, Seed |
| Sofinnova Partners | Series A |
Elevara Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elevara Medicines's valuation, stock price, and market status.
